The total tumor growth from ethanol (0.01%) treated Wild Type (WT) mice (Fig. S17A-D), VTD (0.1 mg/kg) treated heterozygous haploinsufficient UBXN2A (+/−) mice (Fig. 8B–C), and VTD (0.1 mg/kg) treated WT mice (Fig. S17E-H), was measured at the pre-treatment, post-treatment, and terminal stages. This evidence concerns the gene UBXN2A and neoplasm.